A detailed history of Russell Investments Group, Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,267,691 shares of EW stock, worth $94 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,267,691
Previous 661,111 91.75%
Holding current value
$94 Million
Previous $61.1 Million 36.99%
% of portfolio
0.13%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $36.2 Million - $56.9 Million
606,580 Added 91.75%
1,267,691 $83.7 Million
Q2 2024

Aug 08, 2024

SELL
$84.3 - $94.31 $12.1 Million - $13.5 Million
-143,652 Reduced 17.85%
661,111 $61.1 Million
Q1 2024

May 08, 2024

SELL
$72.54 - $95.56 $22.9 Million - $30.1 Million
-315,262 Reduced 28.15%
804,763 $76.9 Million
Q4 2023

Feb 05, 2024

BUY
$61.71 - $77.76 $9.49 Million - $12 Million
153,726 Added 15.91%
1,120,025 $85.4 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $32.3 Million - $43.5 Million
465,862 Added 93.09%
966,299 $66.9 Million
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $8.76 Million - $10.1 Million
107,546 Added 27.37%
500,437 $47.2 Million
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $10.6 Million - $12.1 Million
142,656 Added 57.01%
392,891 $32.5 Million
Q4 2022

Feb 08, 2023

BUY
$68.3 - $87.44 $1.09 Million - $1.39 Million
15,902 Added 6.79%
250,235 $18.7 Million
Q3 2022

Nov 04, 2022

SELL
$82.37 - $107.29 $50.8 Million - $66.2 Million
-616,717 Reduced 72.47%
234,333 $19.4 Million
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $4.4 Million - $6.53 Million
-50,913 Reduced 5.64%
851,050 $81 Million
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $2.31 Million - $2.9 Million
-22,607 Reduced 2.45%
901,963 $106 Million
Q4 2021

Jan 21, 2022

SELL
$106.37 - $130.68 $5.39 Million - $6.63 Million
-50,710 Reduced 5.2%
924,570 $120 Million
Q3 2021

Nov 08, 2021

BUY
$102.91 - $122.75 $955,004 - $1.14 Million
9,280 Added 0.96%
975,280 $110 Million
Q2 2021

Aug 04, 2021

SELL
$83.84 - $104.76 $10.6 Million - $13.3 Million
-126,950 Reduced 11.62%
966,000 $100 Million
Q1 2021

May 10, 2021

SELL
$78.68 - $90.67 $5.87 Million - $6.77 Million
-74,640 Reduced 6.39%
1,092,950 $91.4 Million
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $17.4 Million - $22.2 Million
243,110 Added 26.3%
1,167,590 $106 Million
Q3 2020

Nov 09, 2020

BUY
$67.19 - $87.44 $40.6 Million - $52.9 Million
604,505 Added 188.92%
924,480 $73.6 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $15.3 Million - $20.5 Million
266,360 Added 496.8%
319,975 $22 Million
Q1 2020

May 06, 2020

SELL
$52.41 - $81.0 $1.02 Million - $1.58 Million
-19,541 Reduced 26.71%
53,615 $10.3 Million
Q4 2019

Jan 29, 2020

BUY
$71.7 - $82.09 $1.66 Million - $1.9 Million
23,151 Added 46.3%
73,156 $17 Million
Q3 2019

Nov 01, 2019

SELL
$61.55 - $75.43 $186,865 - $229,005
-3,036 Reduced 5.72%
50,005 $10.9 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $1.42 Million - $1.64 Million
-25,418 Reduced 32.4%
53,041 $9.81 Million
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $916,854 - $1.23 Million
19,145 Added 32.28%
78,459 $15 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $9.56 Million - $11.7 Million
-206,051 Reduced 77.65%
59,314 $9.03 Million
Q3 2018

Oct 26, 2018

BUY
$45.7 - $58.03 $1.54 Million - $1.96 Million
33,720 Added 14.56%
265,365 $46 Million
Q2 2018

Aug 08, 2018

SELL
$42.45 - $51.3 $5.27 Million - $6.37 Million
-124,088 Reduced 34.88%
231,645 $33.8 Million
Q1 2018

May 11, 2018

BUY
$37.19 - $47.45 $1.83 Million - $2.34 Million
49,212 Added 16.06%
355,733 $49.5 Million
Q4 2017

Feb 06, 2018

SELL
$33.79 - $39.39 $86,941 - $101,350
-2,573 Reduced 0.83%
306,521 $35.1 Million
Q3 2017

Nov 07, 2017

BUY
$36.29 - $38.83 $11.2 Million - $12 Million
309,094
309,094 $33.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.